Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine · 2024
Platelet-Poor Plasma for the Treatment of Acute Hamstring Muscle Injuries in Collegiate Football Athletes: A Cohort Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kruse Ryan C, Volfson Elena
Аннотация
OBJECTIVE: To evaluate the efficacy of platelet-poor plasma injections for the treatment of acute hamstring muscle strains.
DESIGN: Cohort study.
SETTING: Outpatient Sports Medicine Clinic.
PARTICIPANTS: Twenty consecutive patients with an acute hamstring muscle injury from 2021 to 2022 were included.
INTERVENTIONS: Platelet-poor plasma injection into the hamstring muscle strain.
MAIN OUTCOME MEASURES: Time (days) until return to full unrestricted participation in sport.
RESULTS: All patients were male collegiate football athletes, with an average age of 20 (±1.6) years old. The most commonly injured muscle was the semitendinosus (65%). After treatment with platelet-poor plasma, patients on average returned to full, unrestricted participation in sport at 29.4 (±7.2) days postinjury, with a statistically significant improvement in pain as early as 2 weeks postinjection. No recurrent injuries to the affected hamstring muscles were seen within 12 months.
CONCLUSIONS: PPP may be a safe and effective treatment for acute hamstring muscle strains and may potentially expedite time to return to play.
DESIGN: Cohort study.
SETTING: Outpatient Sports Medicine Clinic.
PARTICIPANTS: Twenty consecutive patients with an acute hamstring muscle injury from 2021 to 2022 were included.
INTERVENTIONS: Platelet-poor plasma injection into the hamstring muscle strain.
MAIN OUTCOME MEASURES: Time (days) until return to full unrestricted participation in sport.
RESULTS: All patients were male collegiate football athletes, with an average age of 20 (±1.6) years old. The most commonly injured muscle was the semitendinosus (65%). After treatment with platelet-poor plasma, patients on average returned to full, unrestricted participation in sport at 29.4 (±7.2) days postinjury, with a statistically significant improvement in pain as early as 2 weeks postinjection. No recurrent injuries to the affected hamstring muscles were seen within 12 months.
CONCLUSIONS: PPP may be a safe and effective treatment for acute hamstring muscle strains and may potentially expedite time to return to play.